Note 8 - Segment Information and Disaggregated Revenue

9 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8.

Segment Information

and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe, for the

three

months ended

March 31, 2020

and

2019

were

$2,573

and

$1,878,

respectively and for the

nine

months ended

March 31, 2020

and

2019

were

$6,918

and

$4,391,

respectively.

Financial information relating to the

three

months ended

March 31, 2020

and

2019

operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (loss)			Depreciation		Expenditures
Contract Manufacturing	2020	$	10,775	$	2,558	$	13,333	$	1,772		$	78	$	49
	2019		11,913		1,875		13,788		1,994			68		63
Branded Proprietary Products	2020		1		2		3		(36	)		-		2
	2019		14		3		17		7			-		-
Other Nutraceutical Businesses	2020		282		13		295		116			1		6
	2019		283		-		283		92			1		-
Total Company	2020		11,058		2,573		13,631		1,852			79		57
	2019		12,210		1,878		14,088		2,093			69		63

Financial information relating to the

nine

months ended

March 31, 2020

and

2019

operations by business segment and disaggregated revenues was as follows:

			Sales, Net						Segment
			U.S.		International				Gross					Capital
			Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2020		$	31,277	$	6,844	$	38,121	$	4,949		$	237	$	150
		2019		31,066		4,330		35,396		4,323			199		350
Branded Proprietary Products	2020			5		12		17		(67	)		-		2
	2019			133		22		155		49			-		-
Other Nutraceutical Businesses	2020			1,034		62		1,096		395			2		6
	2019			803		39		842		271			2		-
Total Company	2020			32,316		6,918		39,234		5,277			239		158
	2019			32,002		4,391		36,393		4,643			201		350

	Total Assets as of
	March 31,		June 30,
	2020		2019
Contract Manufacturing	$	18,416	$	17,580
Branded Proprietary Products		357		427
Other Nutraceutical Businesses		1,872		1,783
Total Company	$	20,645	$	19,790